Archive for the ‘Business’ Category
Emergent BioSolutions Awarded HHS Contract Valued at Up to $107 Million to Develop Large-Scale Manufacturing for BioThrax
ROCKVILLE, Md., Jul 14, 2010
Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has signed a contract valued at up to $107 million with the Office of the Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services (HHS), to develop and obtain regulatory approval for large-scale [...]
In: Business, Chief Exeutive Officer, Emergent Bioslutions, Food and Drug Administration · Tagged with: Anthrax vaccines, Biothrax, Emergent BioSolutions, Food and Drug Administration, Infectious disease, US government
Emergent BioSolutions to Participate in June 2010 Investor Conferences
Fuad El-Hibri, CEO of Emergent BioSolutions Inc., announces that the company will be participating in the following investor conferences during June 2010:
The Jefferies & Company 2010 Global Life Sciences Conference
New [...]
In: Business, Chief Exeutive Officer, Emergent Bioslutions, Fuad El-Hibri, Healthcare Conference · Tagged with: Business, Emergent Biosolutions Inc, Fuad El-Hibri, Healthcare Conference, Jefferies & Company, United States, Webcast
Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding International Business Leader
ROCKVILLE, Md., Mar 11, 2010 (BUSINESS WIRE) — Emergent BioSolutions Inc. (EBS 15.96, -0.03, -0.19%) announced today that Fuad El-Hibri, its chairman and chief executive officer, has been named by the World Trade Center Institute (WTCI) as one of Maryland’s outstanding international business leaders. Celebrating the spirit of global ambition and excellence in international leadership, [...]
In: Business, Chief Exeutive Officer, Emergent Bioslutions, Fuad El-Hibri, United States · Tagged with: Business, Emergent BioSolutions, Fuad El-Hibri, Maryland